. EDNRB isoform and TCGA probe chart. Shown are the exons present in each of the major EDNRB isoforms. "X" marks which exons are detected by which TCGA exon expression probes. Probe 7 (Exon 1b) detects one of the splice variants encoding for the EDNRB-442 isoform, but as this exon is non-coding and is spliced out of other EDNRB-442 isoforms, it does not represent expression of all EDNRB-442 variants.
Supplementary Figure S1 . HEPG2 expression of EDNRB isoforms. RNA isolated from HEPG2 liver carcinoma cells was tested by RT-qPCR for EDNRB isoform expression. Note that overall EDNRB expression is lower in HEPG2 cells compared to most of the tested breast cancer cell lines; furthermore, EDNRB-532 appears to the predominant isoform in these cells.
Supplementary Figure S2 . EDNRB Western blots of cell lines using alternate antibody. A EDNRB-specific antibody (Santa Cruz H-74) that detects all major full-length isoforms of EDNRB was used to probe lysates from HMEC, MCF-7, and MDA-MB-231 cells. Similar expression was observed with this antibody as seen with the EDNRB-442/532 antibody shown in Figure 2 .
Supplementary Figure S3 . Knock-down of both EDNRB-442 and EDNRB-532 with EDNRB-siRNA. MDA-MB-231 cells transfected with siRNA specific to EDNRB showed decreased levels of both EDNRB-442 and 532 variants.
Supplementary Figure S4 . EDNRB over-expression in plasmid-transfected cells. MDA-MB-231 cells transfected with plasmids expressing EDNRB-442, EDNRB-532, and EDNRB-436 were probed with antibodies specific for EDNRB, GFP, and DDK, respectively. These blots verify efficient protein expression of all three plasmids.
Supplementary Figure S5: Effect of EDNRB-442 on MCF-7 invasion toward ET3.
Transfecting EDNRB-442 resulted in a non-significant trend of increased invasion in MCF-7 cells (p=0.08) over 3 biological replicates.
